» Articles » PMID: 37745008

Safety and Aesthetic Outcomes of SERASYNTH MESH BR for Direct-to-implant Breast Reconstruction: A Retrospective Single Center Analysis of 32 Consecutive Cases

Overview
Journal JPRAS Open
Specialty General Surgery
Date 2023 Sep 25
PMID 37745008
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bilateral mastectomy for both therapeutic and prophylactic reasons is becoming increasingly important. To achieve good results after mastectomy, synthetic meshes are often used as an alternative to acellular dermal matrices (ADMs). The aim of this study is to analyze the results of subcutaneous mastectomies and direct-to-implant breast reconstruction using SERASYNTH MESH BR.

Methods: In this work, data from mastectomies ( = 32) in 22 patients without prior radiation after breast reconstruction with SERASYNTH MESH BR from a single center were retrospectively analyzed with 1 year follow-up. Complications were categorized as serious (need for revision surgery) and minor events. Statistical analysis was performed using the -test in SPSS. Data were compared with the existing literature.

Results: Major complications occurred in 15.6% ( = 5). Two out of five revisions were due to hematoma. In three cases, a seroma followed by other complications (e.g., infections, necrosis) necessitated revision. Minor complications occurred in 12.5% of cases. Due to the safety aspect, implants were replaced in each revision. There was no significant difference in complication rates between prophylactic and therapeutic mastectomies ( = 0.3815, SE = 0.171). There was no statistically significant difference in esthetic outcomes ( = 0.3846).

Conclusion: The application of the absorbable polymer poly-p-dioxanone SERASYNTH MESH BR has complication rates comparable to those reported in the existing literature. Careful patient selection is paramount in order to limit the complication rate. SERASYNTH MESH BR can be considered a safe tool to achieve esthetic results in combination with direct-to-implant breast reconstruction.

References
1.
Cordeiro P, Albornoz C, McCormick B, Hu Q, Van Zee K . The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg. 2014; 134(4):588-595. DOI: 10.1097/PRS.0000000000000523. View

2.
Ho A, Bovill E, Macadam S, Tyldesley S, Giang J, Lennox P . Postmastectomy radiation therapy after immediate two-stage tissue expander/implant breast reconstruction: a University of British Columbia perspective. Plast Reconstr Surg. 2014; 134(1):1e-10e. DOI: 10.1097/PRS.0000000000000292. View

3.
de Blacam C, Momoh A, Colakoglu S, Slavin S, Tobias A, Lee B . Cost analysis of implant-based breast reconstruction with acellular dermal matrix. Ann Plast Surg. 2011; 69(5):516-20. DOI: 10.1097/SAP.0b013e318217fb21. View

4.
Spear S, Pelletiere C . Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants. Plast Reconstr Surg. 2004; 113(7):2098-103. DOI: 10.1097/01.prs.0000122406.99750.c3. View

5.
Dieterich M, Reimer T, Dieterich H, Stubert J, Gerber B . A short-term follow-up of implant based breast reconstruction using a titanium-coated polypropylene mesh (TiLoop(®) Bra). Eur J Surg Oncol. 2012; 38(12):1225-30. DOI: 10.1016/j.ejso.2012.08.026. View